M&A Deal Summary |
|
---|---|
Date | 2022-04-18 |
Target | Epic Staffing Group |
Sector | Staffing |
Buyer(s) | TPO |
Sellers(s) | Webster Equity Partners |
Deal Type | Secondary Buyout |
SEARCH BY
Try For Free 7-Day Free Trial
DEAL STATS | # |
---|---|
Overall | 11 of 11 |
Sector (Staffing) | 1 of 1 |
Type (Secondary Buyout) | 4 of 4 |
State (California) | 1 of 1 |
Country (United States) | 11 of 11 |
Year (2022) | 2 of 2 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2022-01-04 |
Clearwave Fiber
Savannah, Georgia, United States Clearwave Fiber is a rural broadband provider serving communities in Illinois, Florida, Alabama, Georgia and South Carolina. Clearwave Fiber was founded in 2022 and is based in Savannah, Georgia. |
Buy | - |
Category | Private Equity Firm |
---|---|
Founded | 2003 |
PE ASSETS | 6.8B USD |
Size | Mega |
Type | Sector Focused |
Webster Capital is a private equity firm that targets growth capital and buyout investments in profitable, middle-market healthcare and consumer companies. Prospective business characteristics of interest include differentiated products or services, distinctive brands, and loyal/repeat customers. Webster looks for companies generating sales of $20 to $200 million, EBITDA of $5 to $20 million, and valued up to $200 million. Webster Capital was formed in 2003 and is based in Waltham, Massachusetts.
DEAL STATS | # |
---|---|
Overall | 19 of 19 |
Sector (Staffing) | 2 of 2 |
Type (Secondary Buyout) | 6 of 6 |
State (California) | 3 of 3 |
Country (United States) | 19 of 19 |
Year (2022) | 1 of 1 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2022-03-01 |
Oceans Healthcare
Plano, Texas, United States Oceans Healthcare is a behavioral health provider focuses on providing geropsychiatric treatment services to patients age 55 and older, and is focused on treating dementia-related or other progressive mental illness. Oceans Healthcare was founded in 2004 and is based in Plano, Texas. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2022-06-23 |
Radius Health
Boston, Massachusetts, United States Radius Health is a global biopharmaceutical company focused on addressing unmet medical needs in the areas of bone health, neuro- orphan diseases, and oncology. Radius’ lead product, TYMLOS® (abaloparatide) injection, was approved by the U.S. Food and Drug Administration for the treatment of postmenopausal women with osteoporosis at high risk for fracture. Radius Health was founded in 2003 and is based in Boston, Massachusetts. |
Buy | $890M |